Is KALA BIO, Inc. (KALA) a Buy, Sell, or Hold?
NASDAQ : KALA
KALA BIO, Inc. — Institutional Ownership
$0.755 USD
$0.01 (0.96%)
- Volume
- 124.22K
- Average Volume
- 117.39K
- Market Capitalization
- $14.6M
- P/E Ratio
- -0.26
- Dividend Yield
- 0.00%
- Price Target
- $18.25
- Year High
- $1030.00
- Year Low
- $0.59
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.91
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-02 | Lazar David E. | 719.4K | 3.90% |
| 2026-05-15 | Baker Bros. Advisors LP | 2312.0 | 0.01% |
| 2026-02-17 | Baker Bros. Advisors LP | 2.89M | 9.99% |
| 2026-02-06 | David E. Lazar | 49.5M | 5.18% |
| 2026-01-13 | LifeSci Capital LLC | 2.2M | 7.90% |
| 2025-12-03 | OXFORD FINANCE LLC | 1.62M | 16.50% |
| 2025-11-14 | Perceptive Advisors LLC | - | 0.00% |
| 2025-11-14 | Point72 Asset Management, L.P. | 257.0 | 0.00% |
| 2025-11-14 | Cormorant Asset Management, LP | - | 0.00% |
| 2025-10-15 | SR One Capital Partners II, LP | 344.18K | 4.60% |
| 2025-10-15 | Simeon George | 344.18K | 4.60% |
| 2025-10-15 | SR One Capital Management, LLC | 344.18K | 4.60% |
| 2025-10-15 | SR One Capital Fund II Aggregator, LP | 344.18K | 4.60% |
| 2025-10-03 | Baker Bros. Advisors LP | 744.76K | 9.99% |
| 2025-10-02 | Baker Bros. Advisors (GP) LLC | 744.76K | 9.99% |
| 2025-10-02 | Felix J. Baker | 744.76K | 9.99% |
| 2025-10-02 | Julian C. Baker | 744.76K | 9.99% |
| 2025-10-02 | Baker Bros. Advisors LP | 744.76K | 9.99% |
| 2025-09-11 | Point72 Asset Management, L.P. | 469.23K | 6.70% |
| 2025-09-11 | Perceptive Advisors LLC | 543.74K | 7.70% |
| 2025-05-12 | Millennium Management LLC | - | 0.00% |
| 2025-02-14 | ADAR1 Capital Management, LLC | 298.96K | 4.91% |
| 2025-02-14 | Cormorant Asset Management, LP | 609.03K | 9.99% |
| 2024-12-31 | Felix J. Baker | 1.2M | 19.70% |
| 2024-12-31 | Julian C. Baker | 1.2M | 19.70% |
| 2024-12-31 | Baker Bros. Advisors LP | 1.2M | 19.70% |
| 2024-12-31 | Baker Bros. Advisors (GP) LLC | 1.2M | 19.70% |
| 2024-11-14 | ADAR1 Capital Management GP, LLC | 480.43K | 9.99% |
| 2024-11-14 | ADAR1 Capital Management, LLC | 477.7K | 9.99% |
| 2024-11-14 | Daniel Schneeberger | 477.7K | 9.99% |
| 2024-07-08 | SR One Capital Management, LLC | 445.64K | 9.99% |
| 2024-07-08 | Simeon George | 445.64K | 9.99% |
| 2024-07-08 | SR One Capital Partners II, LP | 445.64K | 9.99% |
| 2024-07-08 | SR One Capital Fund II Aggregator, LP | 445.64K | 9.99% |
| 2024-06-28 | Julian C. Baker | 891.34K | 19.99% |
| 2024-06-28 | Felix J. Baker | 891.34K | 19.99% |
| 2024-06-28 | Baker Bros. Advisors LP | 891.34K | 19.99% |
| 2024-06-28 | Baker Bros. Advisors (GP) LLC | 891.34K | 19.99% |
| 2024-02-16 | Israel A. Englander | 135.1K | 5.00% |
| 2024-02-16 | Millennium Group Management LLC | 135.1K | 5.00% |
| 2024-02-16 | Millennium Management LLC | 135.1K | 5.00% |
| 2023-06-15 | Sam Huang | 228.03K | 9.70% |
| 2023-06-15 | Checkpoint Capital (Master) Fund, LP | 228.03K | 9.70% |
| 2023-06-15 | Checkpoint Capital, LP | 228.03K | 9.70% |
| 2023-01-17 | Israel A. Englander | 133.7K | 8.40% |
| 2023-01-17 | Integrated Core Strategies (US) LLC | 107.2K | 6.70% |
| 2023-01-17 | Millennium Management LLC | 133.7K | 8.40% |
| 2023-01-17 | Millennium Group Management LLC | 133.7K | 8.40% |
| 2022-01-10 | (1) BlackRock, Inc. | 3.13M | 4.80% |
| 2021-11-26 | Lagunita Biosciences, LLC | 5.14M | 7.00% |
| 2021-11-26 | Lagunita Biosciences, LLC | 5.14M | 7.00% |
| 2021-11-26 | Lagunita, LLC | 5.14M | 7.00% |
| 2021-11-26 | Lagunita, LLC | 5.14M | 7.00% |
| 2021-11-26 | Garland Investments, L.P. | 38965.0 | 0.10% |
| 2021-11-26 | Mark S. Blumenkranz | 5.34M | 7.30% |
| 2021-11-26 | Mark S. Blumenkranz | 5.34M | 7.30% |
| 2021-11-26 | Garland Investments, L.P. | 38965.0 | 0.10% |
| 2021-11-24 | Mark S. Blumenkranz | 5.34M | 7.30% |
| 2021-11-24 | Garland Investments, L.P. | 38965.0 | 0.10% |
| 2021-11-24 | Lagunita, LLC | 5.14M | 7.00% |
| 2021-11-24 | Lagunita Biosciences, LLC | 5.14M | 7.00% |
| 2021-10-14 | OrbiMed Advisors LLC | - | 0.00% |
| 2021-10-14 | OrbiMed Capital GP VI LLC | - | 0.00% |
| 2021-10-14 | OrbiMed Capital LLC | - | 0.00% |
| 2021-02-12 | Eventide Asset Management, LLC | 3.45M | 6.20% |
| 2021-02-02 | (1) BlackRock, Inc. | 3.16M | 5.60% |
| 2019-02-12 | Wellington Investment Advisors Holdings LLP | 1.53M | 4.51% |
| 2019-02-12 | Wellington Management Group LLP | 1.53M | 4.51% |
| 2019-02-12 | Hadley Harbor Master Investors (Cayman) L.P. | - | 0.00% |
| 2019-02-12 | Wellington Group Holdings LLP | 1.53M | 4.51% |
| 2018-02-14 | Peter Kolchinsky | 2.11M | 9.10% |
| 2018-02-14 | RA Capital Management, LLC | 2.11M | 9.10% |
| 2018-02-12 | Patrick G. Enright | 2.28M | 9.30% |
| 2018-02-12 | Juliet Tammenoms Bakker | 2.28M | 9.30% |
| 2018-02-12 | Gregory Grunberg | 2.28M | 9.30% |
| 2018-02-12 | Longitude Venture Partners II, L.P. | 2.27M | 9.30% |
| 2018-02-12 | Longitude Capital Partners II, LLC | 2.27M | 9.30% |
| 2018-02-07 | Charles B. Johnson | 1.4M | 5.40% |
| 2018-01-12 | Samuel D. Isaly | 2.69M | 10.98% |
| 2018-01-12 | OrbiMed Capital GP VI LLC | 2.69M | 10.98% |
| 2018-01-12 | OrbiMed Advisors LLC | 2.69M | 10.98% |
| 2017-08-10 | Wellington Management Group LLP | 2.86M | 11.84% |
| 2017-08-10 | Wellington Management Company LLP | 2.82M | 11.65% |
| 2017-08-10 | Wellington Group Holdings LLP | 2.86M | 11.84% |
| 2017-08-10 | Wellington Investment Advisors Holdings LLP | 2.86M | 11.84% |
| 2017-07-31 | Hadley Harbor Master Investors (Cayman) L.P. | 1.74M | 7.45% |
KALA Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $27.80 | 8.15M | $226.52M | $7.56M | -$ | $218.97M |
| 2024-12-31 | $347.00 | 5.52M | $1.92B | $51.18M | $32.25M | $1.9B |
| 2023-12-31 | $350.00 | 2.43M | $851.2M | $50.9M | $36.32M | $836.63M |
| 2022-12-31 | $1907.50 | 1.52M | $2.9B | $70.5M | $42.95M | $2.87B |
| 2021-12-31 | $3025.00 | 1.3M | $3.94B | $92.14M | $80.19M | $3.93B |
| 2020-12-31 | $16950.00 | 1.05M | $17.76B | $77.26M | $100.92M | $17.78B |
| 2019-12-31 | $9225.00 | 684.2K | $6.31B | $85.45M | $101.18M | $6.33B |
| 2018-12-31 | $12225.00 | 535.08K | $6.54B | $170.9M | $99.44M | $6.47B |
| 2017-12-31 | $46225.00 | 425.5K | $19.67B | $114.56M | $18.65M | $19.57B |
| 2016-12-31 | $46225.00 | 345.67K | $15.98B | $45.47M | $9.65M | $15.94B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8.65 | 8.15M | $70.48M | $1.76M | -$ | $68.72M |
| 2025-12-31 | $27.80 | 8.15M | $226.52M | $7.56M | -$ | $218.97M |
| 2025-09-30 | $76.50 | 7.04M | $538.75M | $21.1M | $29.94M | $547.59M |
| 2025-06-30 | $238.00 | 6.51M | $1.55B | $31.94M | $29.93M | $1.55B |
| 2025-03-31 | $286.50 | 6.35M | $1.82B | $42.22M | $32.35M | $1.81B |
| 2024-12-31 | $347.00 | 4.69M | $1.63B | $51.18M | $32.25M | $1.61B |
| 2024-09-30 | $285.00 | 4.63M | $1.32B | $49.2M | $37.04M | $1.31B |
| 2024-06-30 | $344.50 | 3.03M | $1.04B | $54.2M | $36.8M | $1.03B |
| 2024-03-31 | $399.50 | 2.81M | $1.12B | $48.48M | $36.56M | $1.11B |
| 2023-12-31 | $350.00 | 2.71M | $949.37M | $50.9M | $36.32M | $934.79M |
| 2023-09-30 | $445.00 | 2.55M | $1.13B | $56.06M | $36.08M | $1.11B |
| 2023-06-30 | $729.50 | 2.39M | $1.74B | $49.26M | $33.57M | $1.73B |